Gastroprotection and lysosomal membrane stabilization by sulglicotide

Area of Science:

• Gastroenterology
• Pharmacology
• Cell Biology

Background:

• Gastric ulcer-inducing agents reduce lysosomal stability, releasing lytic enzymes.
• Certain antiulcer and cytoprotective agents exhibit lysosomal membrane stabilizing activity.

Purpose of the Study:

• To investigate the lysosomal membrane stabilizing activity of sulglicotide (Gliptide).
• To compare the efficacy of sulglicotide with carbenoxolone and 16,16-dimethyl-PGE2.

Main Methods:

• In vitro and ex vivo experiments using rat models.
• Assessing lysosomal membrane stability and enzyme release (acid phosphatase).
• Oral and intravenous administration of test compounds.

Main Results:

• Sulglicotide stabilized lysosomal membranes in vitro (9-36 µg/ml) and ex vivo in rats.
• Sulglicotide showed dose-dependent stabilization after intravenous treatment.
• Sulglicotide prevented acid phosphatase release in ethanol-challenged stomachs, indicating cytoprotection.

Conclusions:

• Sulglicotide is a potent in vitro and ex vivo lysosomal membrane stabilizer.
• This stabilizing activity likely contributes to sulglicotide's cytoprotective effects in ulcer models.
• Sulglicotide presents a potential therapeutic agent for gastric ulcers.